Congress of the European Sleep Research Society 2018
The 24th Congress of the European Sleep Research Society was held in Basel, Switzerland, from September 25 to September 28, 2018. It brought together researchers and clinicians working in the field of sleep research and sleep medicine intent on promoting research on sleep and related areas, to improve the care for patients with sleep disorders.
The Professor of Medicine at the University of New South Wales highlighted the latest knowledge in sleep apnea phenotyping and its crucial role in the development of targeted pharmacotherapies to treat OSA.
The neurologist and sleep specialist spoke about data from one of many studies investigating solriamfetol for treatment of narcolepsy and obstructive sleep apnea with remaining excessive daytime sleepiness.
Chylinski spoke about the relationship between the increased number of arousals during sleep and the pathogenesis of Alzheimer disease.
About the 24th Congress of the European Sleep Research Society:
The 24th Congress of the European Sleep Research Society brings together researchers and clinicians intent on promoting research on sleep and related areas to improve the care for patients with sleep disorders. NeurologyLive offers the most up-to-date information regarding existing treatment options, as well as data from clinical trials evaluating new and emerging therapies, to those unable to travel to network with the European Sleep Research Society in Basel.
This Conference Coverage page at NeurologyLive is a full-service resource center for the latest from ESRS 2018, including key developments from research that may potentially lead to a better understanding of sleep disorder causes, methods of early diagnosis, symptom management, and prevention. It serves as a hub of information and news from the conference and includes focal coverage right from the floor.
For related content, check out NeurologyLive’s sleep medicine Condition Center page.